You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,821,927

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,821,927 protect, and when does it expire?

Patent 8,821,927 protects TYKERB and is included in one NDA.

This patent has twenty-eight patent family members in twenty-six countries.

Summary for Patent: 8,821,927

Patent landscape, scope, and claims:

Title:	Pharmaceutical composition
Abstract:	Oral pharmaceutical formulations containing ditosylate salts of 4-quinazolineamines are described as well as methods of using the same in the treatment of disorders characterized by aberrant erbB family PTK activity.
Inventor(s):	Carter; Barry Howard (Kinston, NC), Campbell; Dwayne A (Durham, NC)
Assignee:	SmithKline Beecham (Cork) Limited (Carrigaline, County Cork, IE)
Application Number:	11/911,843
Patent Claim Types: see list of patent claims	Formulation; Compound; Dosage form; Process;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 8,821,927

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Novartis	TYKERB	lapatinib ditosylate	TABLET;ORAL	022059-001	Mar 13, 2007	AB	RX	Yes	Yes	8,821,927	⤷ Subscribe	Y	Y			⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 8,821,927

PCT Information
PCT Filed	April 18, 2006	PCT Application Number:	PCT/US2006/014447
PCT Publication Date:	October 26, 2006	PCT Publication Number:	WO2006/113649

International Family Members for US Patent 8,821,927

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	054252	⤷ Subscribe
Australia	2006236423	⤷ Subscribe
Brazil	PI0609962	⤷ Subscribe
Canada	2606207	⤷ Subscribe
China	101203211	⤷ Subscribe
Cyprus	1118179	⤷ Subscribe
Denmark	1871347	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.